Evaluation of the effect of the EGFR antibody-drug conjugate ABT-414 on QT interval prolongation in patients with advanced solid tumors likely to over-express EGFR
2017 ◽
Vol 79
(5)
◽
pp. 915-922
◽
2019 ◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 36
(15_suppl)
◽
pp. 5565-5565
◽